Comparison of phosphatidylinositol-3-kinase signalling within a panel of human colorectal cancer cell lines with mutant or wild-type PIK3CA

Christopher J. Morrow, Alexander Gray, Caroline Dive

    Research output: Contribution to journalArticle

    25 Citations (Scopus)

    Abstract

    Recent studies have identified conserved missense mutations in PIK3CA, the gene encoding the catalytic phosphatidylinositol-3-kinase subunit p110α, in a variety of human cancers. Further investigation demonstrated that PIK3CA mutations lead to increased basal phosphatidylinositol-3-kinase activity, promoting cell growth and invasion [Samuels, Y., Diaz, L.A., Jr., Schmidt-Kittler, O., Cummins, J.M., Delong, L., Cheong, I., Rago, C., Huso, D.L., Lengauer, C., Kinzler, K.W., Vogelstein, B. and Velculescu, V.E. (2005) Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7, 561-573]. A panel of commonly used colorectal cancer cell lines was screened for these PIK3CA mutations. Constitutive and IGF-1-stimulated phosphatidylinositol-3-kinase activity, signal response and duration were assessed. In the assays used no differences distinguished cells carrying PIK3CA mutations indicating that these mutations did not significantly alter growth factor stimulated or steady state phosphatidylinositol-3-kinase activity in normal cell culture conditions.

    Original languageEnglish
    Pages (from-to)5123-5128
    Number of pages6
    JournalFEBS Letters
    Volume579
    Issue number23
    DOIs
    Publication statusPublished - 26 Sep 2005

    Fingerprint

    Phosphatidylinositol 3-Kinase
    Colorectal Neoplasms
    Cells
    Cell Line
    Cell growth
    Mutation
    Gene encoding
    Neoplasms
    Insulin-Like Growth Factor I
    Cell culture
    Missense Mutation
    Assays
    Intercellular Signaling Peptides and Proteins
    Cell Culture Techniques
    Growth
    Genes

    Keywords

    • Colorectal cancer
    • HCT 116
    • HT29
    • PI3-K p110α mutation
    • PKB/AKT

    Cite this

    @article{2bba8faa26864e56a585beb4ea1d0c05,
    title = "Comparison of phosphatidylinositol-3-kinase signalling within a panel of human colorectal cancer cell lines with mutant or wild-type PIK3CA",
    abstract = "Recent studies have identified conserved missense mutations in PIK3CA, the gene encoding the catalytic phosphatidylinositol-3-kinase subunit p110α, in a variety of human cancers. Further investigation demonstrated that PIK3CA mutations lead to increased basal phosphatidylinositol-3-kinase activity, promoting cell growth and invasion [Samuels, Y., Diaz, L.A., Jr., Schmidt-Kittler, O., Cummins, J.M., Delong, L., Cheong, I., Rago, C., Huso, D.L., Lengauer, C., Kinzler, K.W., Vogelstein, B. and Velculescu, V.E. (2005) Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7, 561-573]. A panel of commonly used colorectal cancer cell lines was screened for these PIK3CA mutations. Constitutive and IGF-1-stimulated phosphatidylinositol-3-kinase activity, signal response and duration were assessed. In the assays used no differences distinguished cells carrying PIK3CA mutations indicating that these mutations did not significantly alter growth factor stimulated or steady state phosphatidylinositol-3-kinase activity in normal cell culture conditions.",
    keywords = "Colorectal cancer, HCT 116, HT29, PI3-K p110α mutation, PKB/AKT",
    author = "Morrow, {Christopher J.} and Alexander Gray and Caroline Dive",
    year = "2005",
    month = "9",
    day = "26",
    doi = "10.1016/j.febslet.2005.07.096",
    language = "English",
    volume = "579",
    pages = "5123--5128",
    journal = "FEBS Letters",
    issn = "0014-5793",
    publisher = "Wiley",
    number = "23",

    }

    Comparison of phosphatidylinositol-3-kinase signalling within a panel of human colorectal cancer cell lines with mutant or wild-type PIK3CA. / Morrow, Christopher J.; Gray, Alexander; Dive, Caroline.

    In: FEBS Letters, Vol. 579, No. 23, 26.09.2005, p. 5123-5128.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Comparison of phosphatidylinositol-3-kinase signalling within a panel of human colorectal cancer cell lines with mutant or wild-type PIK3CA

    AU - Morrow, Christopher J.

    AU - Gray, Alexander

    AU - Dive, Caroline

    PY - 2005/9/26

    Y1 - 2005/9/26

    N2 - Recent studies have identified conserved missense mutations in PIK3CA, the gene encoding the catalytic phosphatidylinositol-3-kinase subunit p110α, in a variety of human cancers. Further investigation demonstrated that PIK3CA mutations lead to increased basal phosphatidylinositol-3-kinase activity, promoting cell growth and invasion [Samuels, Y., Diaz, L.A., Jr., Schmidt-Kittler, O., Cummins, J.M., Delong, L., Cheong, I., Rago, C., Huso, D.L., Lengauer, C., Kinzler, K.W., Vogelstein, B. and Velculescu, V.E. (2005) Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7, 561-573]. A panel of commonly used colorectal cancer cell lines was screened for these PIK3CA mutations. Constitutive and IGF-1-stimulated phosphatidylinositol-3-kinase activity, signal response and duration were assessed. In the assays used no differences distinguished cells carrying PIK3CA mutations indicating that these mutations did not significantly alter growth factor stimulated or steady state phosphatidylinositol-3-kinase activity in normal cell culture conditions.

    AB - Recent studies have identified conserved missense mutations in PIK3CA, the gene encoding the catalytic phosphatidylinositol-3-kinase subunit p110α, in a variety of human cancers. Further investigation demonstrated that PIK3CA mutations lead to increased basal phosphatidylinositol-3-kinase activity, promoting cell growth and invasion [Samuels, Y., Diaz, L.A., Jr., Schmidt-Kittler, O., Cummins, J.M., Delong, L., Cheong, I., Rago, C., Huso, D.L., Lengauer, C., Kinzler, K.W., Vogelstein, B. and Velculescu, V.E. (2005) Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7, 561-573]. A panel of commonly used colorectal cancer cell lines was screened for these PIK3CA mutations. Constitutive and IGF-1-stimulated phosphatidylinositol-3-kinase activity, signal response and duration were assessed. In the assays used no differences distinguished cells carrying PIK3CA mutations indicating that these mutations did not significantly alter growth factor stimulated or steady state phosphatidylinositol-3-kinase activity in normal cell culture conditions.

    KW - Colorectal cancer

    KW - HCT 116

    KW - HT29

    KW - PI3-K p110α mutation

    KW - PKB/AKT

    UR - http://www.scopus.com/inward/record.url?scp=24944536147&partnerID=8YFLogxK

    U2 - 10.1016/j.febslet.2005.07.096

    DO - 10.1016/j.febslet.2005.07.096

    M3 - Article

    VL - 579

    SP - 5123

    EP - 5128

    JO - FEBS Letters

    JF - FEBS Letters

    SN - 0014-5793

    IS - 23

    ER -